PEPTIDOPAMIN

Molecular design of biologically inspired soft materials for hard tissue regeneration

 Coordinatore STICHTING KATHOLIEKE UNIVERSITEIT 

 Organization address address: GEERT GROOTEPLEIN NOORD 9
city: NIJMEGEN
postcode: 6525 EZ

contact info
Titolo: Mr.
Nome: Wim
Cognome: Van Oijen
Email: send email
Telefono: +31 243618937
Fax: +31 243540529

 Nazionalità Coordinatore Netherlands [NL]
 Totale costo 185˙363 €
 EC contributo 185˙363 €
 Programma FP7-PEOPLE
Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
 Code Call FP7-PEOPLE-2011-IOF
 Funding Scheme MC-IOF
 Anno di inizio 2012
 Periodo (anno-mese-giorno) 2012-05-01   -   2014-04-30

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    STICHTING KATHOLIEKE UNIVERSITEIT

 Organization address address: GEERT GROOTEPLEIN NOORD 9
city: NIJMEGEN
postcode: 6525 EZ

contact info
Titolo: Mr.
Nome: Wim
Cognome: Van Oijen
Email: send email
Telefono: +31 243618937
Fax: +31 243540529

NL (NIJMEGEN) coordinator 185˙363.40

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

mechanical    cell    peptide    regeneration    related    induce    grafting    materials    ecm    adhesion    adhesive    proteins    shortcomings    bone    formed    hydrogels    artificial    molecules    soft    treat    biologically    dopa    incorporate   

 Obiettivo del progetto (Objective)

'The shortcomings of current medical grafting procedures to treat severe bone defects continue to drive the development of alternative therapies. The clinical success of synthetic bone fillers is still disappointingly limited. Although hydrogels have not been classically studied for bone regeneration applications, owing to their inherently low mechanical properties, these highly hydrated soft materials can provide a proper environment to cell adhesion, migration, proliferation and differentiation, thereby mimicking the regulatory function of natural extracellular matrix (ECM). If successfully regenerated, the newly formed bone would comply with the mechanical requirements. A common feature of mussel-adhesive proteins is the presence of dihydroxyphenylalanine (DOPA), an amino acid formed by posttranslational modification. These proteins adhesive properties can be mimicked by a group of DOPA structurally related molecules, useful for the creation of bioadhesive coatings and hydrogels of great biocompatibility. DOPA-based soft materials can easily incorporate bioactive PEPTIDE molecules. Small peptide mimetics have the ability to reproduce some of the biological roles of biologically related proteins, such as Integrin mediated cell adhesion and capability to induce MINERALIZATION. Thus, intrinsically adhesive and biocompatible hydrogels, which include both cell attachment ligands and prospective hydroxyapatite binding peptides, will be developed to induce the deposition of bone-like mineral in close association with the artificial ECM, under biologically relevant conditions. These artificial ECMs will also incorporate tuned hydrolytically degradable crosslinks, and will be designed to be used as injectable systems for minimally invasive surgical procedures. The overall design aims at creating an artificial ECM that instructs osteogenic and progenitor cells to recapitulate the normal bone healing and morphogenetic processes.'

Introduzione (Teaser)

Current shortcomings in grafting procedures heighten the need for new biomaterials to treat bone lesions. A research study has explored the formulation of biodegradable hydrogels that could be injected at the site of fracture to facilitate bone regeneration.

Altri progetti dello stesso programma (FP7-PEOPLE)

FAEFID (2013)

Characterisation of Fuel Additives Effect on Fuel Injector Design

Read More  

GAEMASS (2011)

Agricultural soils and environmental change: integrating Geomorphic and Agro-Ecosystem Modelling Across Spatial Scales

Read More  

MLPM2012 (2013)

Machine Learning for Personalized Medicine

Read More